Our study suggests that the presence of the minor C allele of rs11212617 might associate with a significant improvement in insulin sensitivity in HER2-positive breast cancer patients subjected to neoadjuvant metformin in combination with trastuzumab and chemotherapy. This evidence concerns the gene ERBB2 and breast cancer.